# STAT3 and STAT6 activation in lung tissues correlates with inflammatory and clinical traits in COPD

## TL;DR

The paper shows that STAT3 and STAT6 activation in lung tissues is linked to specific inflammatory and clinical features in COPD, suggesting potential for targeted therapies.

## Contribution

The study identifies distinct roles of STAT3 and STAT6 in COPD inflammation and clinical traits, offering new therapeutic insights.

## Key findings

- STAT3 activation is associated with neutrophilic inflammation in COPD.
- STAT6 activation correlates with eosinophilic inflammation and chronic bronchitis.
- These findings suggest potential for targeted therapies based on specific COPD traits.

## Abstract

COPD is a heterogeneous respiratory disease caused mainly by cigarette smoking in Western countries. COPD is usually progressive and significantly impacts patients’ quality of life. Breathlessness, cough and sputum production are the most common symptoms, and can acutely exacerbate into potentially fatal events. A chronic inflammatory process underlies the development and progression of the disease [1].

The study highlights the role of JAK/STAT signalling in COPD, with STAT3 linked to neutrophilic inflammation and STAT6 to eosinophilic inflammation and chronic bronchitis. Findings support targeted therapies to address specific clinical traits in COPD.
https://bit.ly/4qoEs0h